Updated:
Hazelden Betty Ford Foundation
Founded in 1949 as a rural treatment farm, the Hazelden Betty Ford Foundation merged in 2014 with the Betty Ford Center and now anchors the nonprofit...
Hazelden Betty Ford Foundation
Founded in 1949 as a rural treatment farm, the Hazelden Betty Ford Foundation merged in 2014 with the Betty Ford Center and now anchors the nonprofit addiction-care sector from its Center City, Minnesota headquarters. Susan Ford Bales serves on the board of trustees, maintaining the family connection to former First Lady Betty Ford's advocacy. The foundation operates 17 inpatient and outpatient sites from Rancho Mirage to New York. The foundation manages an estimated $177M endowment (Altss estimate) with a multi-asset strategy that spans buyouts, growth equity, and special situations, though specific fund commitments and direct holdings are not publicly itemized. Its operational footprint drives revenue through commercial treatment campuses in six states — including the flagship Betty Ford Center, Hazelden Betty Ford St. Paul, and centers in Chicago, New York, Naples, and Newberg. Confirmed institutional partnerships include Emory Healthcare through the Addiction Alliance of Georgia and a digital health tie-up with the startup Ginger for virtual treatment delivery. The board draws on government and recovery circles: North Dakota First Lady Kathryn Burgum serves alongside Susan Ford Bales. In September 2022, the foundation collaborated with Sigma Chi Fraternity to launch the Wayfinder behavioral health portal, extending its reach into university-age populations. The organization holds active memberships in the National Association of Addiction Treatment Providers and the Minnesota Association of Resources for Recovery and Chemical Health, signaling deep integration with sector policy and advocacy networks. The foundation's structural differentiator is its hybrid identity — simultaneously the largest U.S. nonprofit addiction-treatment provider by facility count and an endowment investor that allocates to external fund managers via buyout and growth strategies. This dual posture means the endowment can draw on proprietary diligence from operating commercial treatment centers in Rancho Mirage, St. Paul, and New York, giving its investment team a real-time lens on behavioral-health demand that a purely financial endowment would lack.
General information
Firm type
Endowment / Foundation
Year founded
1949
Location
Region
North America
Country
United States
City
Center City
Corporate office
Center City, Minnesota, United States
Additional offices
Rancho Mirage, CA, United States · St. Paul, MN, United States · Chicago, IL, United States · New York, NY, United States · Naples, FL, United States · Newberg, OR, United States
Principals
Susan Ford Bales
Member of the Board of Trustees
Sector focus
Frequently asked questions
Who runs investment decisions at Hazelden Betty Ford Foundation?
The foundation has not publicly disclosed its investment committee or chief investment officer. Governance flows through a board of trustees that includes Susan Ford Bales and North Dakota First Lady Kathryn Burgum, both recovery advocates. The board ultimately oversees the endowment's allocation to external managers across buyouts, growth equity, and special situations, per Altss research. Day-to-day investment staff names are not a matter of public record.
How is Hazelden Betty Ford structured — is it purely an endowment or does it operate businesses?
It is both a significant operator and an endowment investor. The foundation runs 17 commercial inpatient and outpatient treatment campuses in six states, generating clinical revenue, while simultaneously managing an estimated $177M endowment (Altss estimate). This hybrid structure distinguishes it from grants-only foundations and gives the investment team direct operational exposure to the behavioral-health economy.
Does Hazelden Betty Ford participate in direct healthcare deals or only fund commitments?
The foundation's stated strategy includes buyouts, growth equity, and special situations, but the specific mix of direct investments versus fund commitments is not publicly itemized. No individual portfolio company names from the endowment portfolio have been disclosed. Its known partnerships — such as the Addiction Alliance of Georgia with Emory Healthcare or the digital-health collaboration with Ginger — stem from the operating side rather than the endowment.
What is the foundation's relationship with the Ford family today?
Susan Ford Bales, daughter of former President Gerald Ford and former First Lady Betty Ford, serves on the board of trustees, maintaining the family's active governance role decades after Betty Ford founded the eponymous California treatment center. The 2014 merger between Hazelden and the Betty Ford Center unified the two nonprofits under a single board. No other Ford family members are disclosed as trustees in the Altss research record.
What role do philanthropic or advocacy arms play alongside the endowment?
The foundation is itself the philanthropic entity — its clinical mission is the core operating activity, while the endowment provides financial ballast. Board members like Kathryn Burgum use their platform for state-level recovery advocacy in North Dakota. The foundation also maintains industry-association ties through NAATP and MARRCH, which shape public policy on addiction treatment, though a separate grantmaking foundation has not been disclosed.
How geographically concentrated are Hazelden Betty Ford's treatment assets?
The foundation's 17 sites cluster in six states: Minnesota (Center City and St. Paul are dual anchors), California, Illinois, New York, Florida, and Oregon. This is a deliberate national footprint, not a regional concentration — the Betty Ford Center in Rancho Mirage and the Manhattan outpatient clinic extend the brand to both coasts. Real assets in these locations form a significant portion of the operating balance sheet, per the Altss research record.
What is Hazelden Betty Ford's known posture on co-investments alongside external GPs?
The foundation has not publicly described a co-investment program or any club-deal activity alongside external general partners. Given its estimated $177M endowment (Altss estimate), its allocation is likely executed entirely through commingled fund commitments. No direct co-investment transactions have been reported in connection with the endowment's buyout, growth, or special-situations strategy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: